Abraham J. Al-Ahmad, Ph.D.
Affiliations: | 2004-2009 | Veterinary Physiology | Universität Zürich, Zürich, ZH, Switzerland |
| 2009-2011 | Molecular & Cellular Medicine | Texas A&M Health Science Center, Bryan, TX, United States | |
| 2011-2014 | Chemical & Biological Engineering | University of Wisconsin, Madison, Madison, WI | |
| 2014- | Pharmaceutical Sciences | Texas Tech University Health Sciences Center |
Area:
Blood-brain barrier, Hypoxia, Stroke, Alzheimer's disease, GLUT1 deficiency syndromeGoogle:
"Abraham Al-Ahmad"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Omolara Ogunshola | grad student | 2004-2009 | University of Zurich, Department of Veterinary Physiology |
| Gregory J. Bix | post-doc | 2009-2011 | Texas A&M Health Science Center (Chemistry Tree) |
| Eric V. Shusta | post-doc | 2011-2014 | College of Engineering (Microtree) |
Children
Sign in to add trainee| Ronak Patel | grad student | 2014- | Texas Tech University Health Sciences Center |
| Shyanne Page | grad student | 2015- | Texas Tech University Health Sciences Center |
Collaborators
Sign in to add collaborator| Paul Trippier | collaborator | 2014- | Texas Tech University Health Sciences Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Al-Ahmad AJ. (2023) Human-Induced Pluripotent Stem Cell-Based Model of the Blood-Brain at 10 Years: A Retrospective on Past and Current Disease Models. Handbook of Experimental Pharmacology |
| Noorani B, Chowdhury EA, Alqahtani F, et al. (2023) Effects of Volatile Anesthetics Versus Ketamine on Blood-Brain Barrier Permeability via Lipid-Mediated Alterations of Endothelial Cell Membranes. The Journal of Pharmacology and Experimental Therapeutics |
| Pervaiz I, Zahra FT, Mikelis C, et al. (2022) An in vitro model of glucose transporter 1 deficiency syndrome at the blood-brain barrier using induced pluripotent stem cells. Journal of Neurochemistry |
| Pervaiz I, Al-Ahmad AJ. (2022) In Vitro Models of the Human Blood-Brain Barrier Utilising Human Induced Pluripotent Stem Cells: Opportunities and Challenges. Methods in Molecular Biology (Clifton, N.J.). 2492: 53-72 |
| Raut S, Patel R, Pervaiz I, et al. (2022) Abeta peptides disrupt the barrier integrity and glucose metabolism of human induced pluripotent stem cell-derived brain microvascular endothelial cells. Neurotoxicology. 89: 110-120 |
| Al-Ahmad AJ, Pervaiz I, Karamyan VT. (2021) Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model. Journal of Neuroendocrinology. 33: e12931 |
| Raut S, Patel R, Al-Ahmad AJ. (2021) Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro. Fluids and Barriers of the Cns. 18: 3 |
| Kinarivala N, Morsy A, Patel R, et al. (2020) An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening. Acs Pharmacology & Translational Science. 3: 931-947 |
| Nozohouri S, Noorani B, Al-Ahmad A, et al. (2020) Estimating Brain Permeability Using In Vitro Blood-Brain Barrier Models. Methods in Molecular Biology (Clifton, N.J.) |
| Albekairi TH, Vaidya B, Patel R, et al. (2019) Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP). Pharmaceutics. 11 |